Pam Bondi Faces Scrutiny Over Role as Attorney General

Washington, D.C. — Attorney General Pam Bondi is under intensifying scrutiny for her handling of high‑profile cases, her approach to voting rights, and her ties to corporate interests. Critics argue her record reveals a consistent pattern of incompetence, politicization, and misplaced loyalty that undermines the integrity of the Justice Department. Bondi, a longtime ally of President Trump, has been accused of elevating loyalty to him above impartial enforcement of the law. Observers point to her decision as Florida’s Attorney General to drop investigations into Trump University after receiving campaign donations, saying it foreshadowed her current role in Washington. Her handling … Continue reading Pam Bondi Faces Scrutiny Over Role as Attorney General

Trump’s Greenland Folly: Grounds for Impeachment

President Donald Trump’s renewed push to annex Greenland is not an isolated misstep. It is part of a broader pattern of reckless foreign policy blunders that have weakened America’s alliances, undermined national security, and embarrassed the United States on the world stage. His latest move — appointing a “special envoy” to pursue Greenland as if it were a real estate transaction — is more than foolish. It is dangerous, incompetent, and worthy of impeachment. Trump’s envoy, Louisiana Governor Jeff Landry, declared his mission was to “make Greenland a part of the U.S.” — a statement that immediately provoked outrage in … Continue reading Trump’s Greenland Folly: Grounds for Impeachment

Trump Rebrands Biden’s Drug Reforms as His Own

President Donald Trump this week unveiled sweeping “Most Favored Nation” drug pricing agreements with nine pharmaceutical companies, promising Americans unprecedented discounts on insulin, cancer treatments, and other life‑saving medicines. For millions of families struggling under the weight of prescription costs, the announcement sounded like long‑awaited relief. But policy experts say much of what is being promoted under Trump’s “TrumpRx” program closely mirrors reforms enacted under President Joe Biden, raising concerns about whether the public is being misled about who delivered the underlying changes. The White House highlighted dramatic examples of price reductions, including Plavix dropping from $756 to $16, Epclusa … Continue reading Trump Rebrands Biden’s Drug Reforms as His Own

The BLS Jobs Report in Question

When the Bureau of Labor Statistics (BLS) releases its monthly jobs report, it’s supposed to be one of the least dramatic moments in Washington. For decades, both parties treated the agency as a quiet, technocratic institution where career statisticians did their work far from political pressure. This month’s report arrives in a very different atmosphere — one shaped by an abrupt firing, an unusually long delay in restoring stable leadership, and the looming presence of a new appointee widely viewed as aligned with President Trump politically, ideologically, or administratively. It’s understandable that people feel uneasy. When something that has always … Continue reading The BLS Jobs Report in Question

Tariffs, Cuts, and Clawbacks: Trump’s Economic Threat

Donald Trump has branded his second-term economic program as “America First.” Yet behind the slogans, economists warn that his mix of sweeping tariffs, tax cuts favoring the wealthy, and aggressive Social Security clawbacks could leave ordinary Americans footing the bill. Rising costs, shrinking benefits, and mounting instability suggest that far from protecting families, Trump’s policies may be setting them up for hardship. Still, in the face of these challenges, the resilience of American communities continues to shine. Trump’s universal 10 percent tariff on imports is promoted as a safeguard for U.S. manufacturing. In reality, it acts as a hidden tax … Continue reading Tariffs, Cuts, and Clawbacks: Trump’s Economic Threat

Millions Face Rising Costs as Congress Weighs Health Care Plans

WASHINGTON — With enhanced Affordable Care Act subsidies set to expire at the end of the year, millions of Americans are bracing for sharply higher health insurance premiums. For families who rely on the subsidies to keep monthly costs manageable, and for patients with chronic conditions who depend on stable coverage, the financial gap between competing proposals in Congress is substantial — and potentially life‑changing. The subsidies, expanded under the Biden administration, are scheduled to lapse on Dec. 31. If Congress fails to act, premiums are expected to rise by about $1,000 on average for the more than 20 million … Continue reading Millions Face Rising Costs as Congress Weighs Health Care Plans

Trump’s Tariffs, America’s Bailout

When Donald Trump imposed sweeping tariffs on America’s trading partners, his administration branded them a “lifeline for the middle class.” Supporters claimed tariffs would protect U.S. jobs and industries. But years later, the reality is undeniable: higher consumer prices, disrupted supply chains, lost export markets, and taxpayer-funded bailouts. The latest example came in December 2025, when Trump announced a new $12 billion bailout for farmers. The aid, scheduled to begin distribution in February 2026, is intended to offset losses from retaliatory tariffs that slashed demand for U.S. crops such as soybeans, corn, wheat, and pork. This bailout was not triggered … Continue reading Trump’s Tariffs, America’s Bailout

The Fight for Warner Bros.: A Hostile Bid With High Stakes

The Fight for Warner Bros.: A Hostile Bid With High Stakes David Ellison’s hostile takeover bid for Warner Bros. Discovery has sparked growing alarm across the entertainment industry, political watchdog groups, and media‑freedom advocates, who warn that the attempt carries not just corporate implications but profound risks for the independence of one of the world’s most influential cultural institutions. Yet even in this moment of uncertainty, something powerful is emerging: a renewed awareness of how deeply people depend on free expression, honest journalism, and the creative voices that help us understand ourselves and one another. This isn’t just a business … Continue reading The Fight for Warner Bros.: A Hostile Bid With High Stakes

Trump’s Approval Plummets to 36% as GOP Fractures

Washington, D.C. — December 2025. President Donald Trump is facing some of the lowest approval ratings of his presidency, leaving him politically isolated as Republican lawmakers and allies quietly step back. Recent polls show Trump’s approval sinking into the mid-30s, with disapproval nearing 60%. A Gallup survey in late November placed his approval at 36%, while a Reuters/Ipsos poll recorded 38%, a nine-point drop since Inauguration Day. Even within his own party, support has slipped by seven points in just one month — a rare fracture in a base once considered unshakable. These historically low numbers are more than statistics; … Continue reading Trump’s Approval Plummets to 36% as GOP Fractures

National Guard Ambush in D.C. Raises Questions About Trump’s Deployment, Immigration Policy, and Project 2025

WASHINGTON — The deadly ambush near the Farragut West Metro station on November 26 has intensified scrutiny of President Donald Trump’s deployment of National Guard troops in the nation’s capital, his immigration policies, and his broader Project 2025 agenda. Two West Virginia Guard members were attacked while on patrol; 20‑year‑old Sarah Backstrom was killed, and 24‑year‑old Andrew Wolfe remains in critical condition. The tragedy has left families grieving and communities questioning whether political decisions placed service members in harm’s way. Even amid sorrow, their sacrifice has become a rallying cry for accountability, justice, and hope. In August, Trump ordered more than … Continue reading National Guard Ambush in D.C. Raises Questions About Trump’s Deployment, Immigration Policy, and Project 2025